Exploring the Antitumor Efficacy of N-Heterocyclic Nitrilotriacetate Oxidovanadium(IV) Salts on Prostate and Breast Cancer Cells
Molecules · 2024
DOI: 10.3390/molecules29122924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Katarzyna Chmur und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland. Hauptthemen laut MEDLINE: Antineoplastic Agents, Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Gdansk, Poland, Gdansk University of Technology, Poland, University of Gdansk.
Abstract (Originalsprache)
The crystal structures of two newly synthesized nitrilotriacetate oxidovanadium(IV) salts, namely [QH][VO(nta)(H2O)](H2O)2 (I) and [(acr)H][VO(nta)(H2O)](H2O)2 (II), were determined. Additionally, the cytotoxic effects of four N-heterocyclic nitrilotriacetate oxidovanadium(IV) salts—1,10-phenanthrolinium, [(phen)H][VO(nta)(H2O)](H2O)0.5 (III), 2,2′-bipyridinium [(bpy)H][VO(nta)(H2O)](H2O) (IV), and two newly synthesized compounds (I) and (II)—were evaluated against prostate cancer (PC3) and breast cancer (MCF-7) cells. All the compounds exhibited strong cytotoxic effects on cancer cells and normal cells (HaCaT human keratinocytes). The structure–activity relationship analysis revealed that the number and arrangement of conjugated aromatic rings in the counterion had an impact on the antitumor effect. The compound (III), the 1,10-phenanthrolinium analogue, exhibited the greatest activity, whereas the acridinium salt (II), with a different arrangement of three conjugated aromatic rings, showed the lowest toxicity. The increased concentrations of the compounds resulted in alterations to the cell cycle distribution with different effects in MCF-7 and PC3 cells. In MCF-7 cells, compounds I and II were observed to block the G2/M phase, while compounds III and IV were found to arrest the cell cycle in the G0/G1 phase. In PC3 cells, all compounds increased the rates of cells in the G0/G1 phase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308 Gdańsk, Poland.
- Department of Inorganic Chemistry, Gdańsk University of Technology, Narutowicza 11/12, 80-233 Gdańsk, Poland.
ORCID-Profile: Katarzyna Chmur, Magdalena Zdrowowicz, Jarosław Chojnacki, Dariusz Wyrzykowski
Förderung
- University of Gdansk, Poland
- Gdansk University of Technology, Poland
- University of Gdansk
- Gdansk University of Technology
Zitieren
APA
Chmur, K., Tesmar, A., Zdrowowicz, M., Rosiak, D., Chojnacki, J., & Wyrzykowski, D. (2024). Exploring the Antitumor Efficacy of N-Heterocyclic Nitrilotriacetate Oxidovanadium(IV) Salts on Prostate and Breast Cancer Cells. Molecules. https://doi.org/10.3390/molecules29122924
Vancouver
Chmur K, Tesmar A, Zdrowowicz M, Rosiak D, Chojnacki J, Wyrzykowski D. Exploring the Antitumor Efficacy of N-Heterocyclic Nitrilotriacetate Oxidovanadium(IV) Salts on Prostate and Breast Cancer Cells. Molecules. 2024. doi:10.3390/molecules29122924
BibTeX
@article{Chmur2024,
author = {Chmur, Katarzyna and Tesmar, Aleksandra and Zdrowowicz, Magdalena and Rosiak, Damian and Chojnacki, Jarosław and Wyrzykowski, Dariusz},
title = {Exploring the Antitumor Efficacy of N-Heterocyclic Nitrilotriacetate Oxidovanadium(IV) Salts on Prostate and Breast Cancer Cells},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29122924}
}
EUVIMED